Search - tctmd.com

Displaying 641 - 660 of 1417

Sort: Relevancy | Date

Presentation TCT 2015

Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits?

Presenter: Stephan Baldus, Saibal Kar, Michael J. Rinaldi

October 14, 2015

Presentation TCT 2015

High-end ADR: Becoming a Master of Controlled ADR

Presenter: J. Aaron Grantham, Ashish Pershad, R. Michael Wyman

October 14, 2015

Presentation TCT 2015

Debate 1: The Requirement for Surgical Involvement in TAVI Planning and Procedures Has Now Passed. I'm Against the Proposal!

Presenter: Adrian P. Banning, Mark A. de Belder, Michael J. Mack

October 14, 2015

Presentation TCT 2015

Real-Time Crossboss and Stingray Demonstration on a model

Presenter: Dimitri Karmpaliotis, William Nicholson, R. Michael Wyman

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

Presentation TCT 2015

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis

October 13, 2015

Presentation TCT 2015

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

Presenter: Michael J. Reardon, Torsten P. Vahl, Henrique Ribeiro

October 13, 2015

Presentation TCT 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen

October 13, 2015

Presentation TCT 2015

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

Presenter: Michael J. Reardon, Torsten P. Vahl, Yingqiang Guo

October 13, 2015

Presentation TCT 2015

TCT 96: Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study

Presenter: Jeffrey J. Popma, Mathew Williams, G. Michael Deeb

October 13, 2015

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Presentation TCT 2015

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

Presenter: Michael J. Reardon, Torsten P. Vahl, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

Presentation TCT 2015

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Matthew Sherwood

October 13, 2015

Presentation TCT 2015

A White Paper From EFS Physician Enthusiasts: Honest Appraisals and Lessons Learned

Presenter: Andrew Farb, Michael J. Mack

October 13, 2015

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

Presentation TCT 2015

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Moritz Seiffert

October 13, 2015

Presentation TCT 2015

The Early Feasibility Study (EFS) Program: First-Term Report Card

Presenter: Andrew Farb, Michael J. Mack

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Advertisement

Pushing the Anatomic Envelope of MitraClip Eligibility: What Are the Limits?

High-end ADR: Becoming a Master of Controlled ADR

Debate 1: The Requirement for Surgical Involvement in TAVI Planning and Procedures Has Now Passed. I'm Against the Proposal!

Real-Time Crossboss and Stingray Demonstration on a model

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

TCT 96: Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

A White Paper From EFS Physician Enthusiasts: Honest Appraisals and Lessons Learned

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

The Early Feasibility Study (EFS) Program: First-Term Report Card

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content